ANPEP and cancer: The distinct aberrant cancer-associated glycans on CD13 as observed may represent an important cancer biomarker and target for anti-cancer-specific therapy. Glycoform-specific targeting of proteins in recent years has been demonstrated as an effective approach to limit off-target toxicities associated with current anti-cancer therapy, while increasing the antitumor specificity.45